EMvision Medical Valuation
EMV Stock | 1.98 0.02 1.02% |
Based on Macroaxis valuation methodology, the firm appears to be fairly valued. EMvision Medical Devices shows a prevailing Real Value of USD1.97 per share. The current price of the firm is USD1.98. Our model computes the value of EMvision Medical Devices from reviewing the firm fundamentals such as Profit Margin of (0.24) %, price to book of 9.14 X, and Current Valuation of 153.55 M as well as analyzing its technical indicators and probability of bankruptcy.
Price Book 9.1448 | Enterprise Value 153.6 M | Enterprise Value Ebitda (21.53) | Price Sales 15.0922 |
Fairly Valued
Today
Please note that EMvision Medical's price fluctuation is risky at this time. Calculation of the real value of EMvision Medical Devices is based on 3 months time horizon. Increasing EMvision Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
EMvision Medical's intrinsic value may or may not be the same as its current market price of 1.98, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 1.98 | Real 1.97 | Hype 1.98 |
The intrinsic value of EMvision Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence EMvision Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of EMvision Medical Devices helps investors to forecast how EMvision stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of EMvision Medical more accurately as focusing exclusively on EMvision Medical's fundamentals will not take into account other important factors: EMvision Medical Cash |
|
EMvision Medical Total Value Analysis
EMvision Medical Devices is currently anticipated to have takeover price of 153.55 M with market capitalization of 169.32 M, debt of 2.9 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the EMvision Medical fundamentals before making investing decisions based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
153.55 M | 169.32 M | 2.9 M |
EMvision Medical Investor Information
About 36.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.03. EMvision Medical Devices had not issued any dividends in recent years. Based on the analysis of EMvision Medical's profitability, liquidity, and operating efficiency, EMvision Medical Devices is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.EMvision Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. EMvision Medical has an asset utilization ratio of 46.8 percent. This implies that the Company is making USD0.47 for each dollar of assets. An increasing asset utilization means that EMvision Medical Devices is more efficient with each dollar of assets it utilizes for everyday operations.EMvision Medical Ownership Allocation
EMvision Medical holds a total of 85.52 Million outstanding shares. EMvision Medical Devices retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.EMvision Medical Profitability Analysis
The company reported the revenue of 11.22 M. Net Loss for the year was (2.73 M) with profit before overhead, payroll, taxes, and interest of 6.97 M.About EMvision Medical Valuation
The stock valuation mechanism determines EMvision Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of EMvision Medical Devices based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of EMvision Medical. We calculate exposure to EMvision Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of EMvision Medical's related companies.Last Reported | Projected for Next Year | ||
Gross Profit | 11.2 M | 11.8 M |
Additional Tools for EMvision Stock Analysis
When running EMvision Medical's price analysis, check to measure EMvision Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EMvision Medical is operating at the current time. Most of EMvision Medical's value examination focuses on studying past and present price action to predict the probability of EMvision Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EMvision Medical's price. Additionally, you may evaluate how the addition of EMvision Medical to your portfolios can decrease your overall portfolio volatility.